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Earlier  studies  (1,  2)  of the  I-anti-I cold agglutinin  system have indicated 
that  the  I  antigenic  determinants  are  complex  and  that  they  are  present  on 
certain  precursors  of A,  B, H, Le  a,  and Le  b substances.  In hemagglutination- 
inhibition  assays several  anti-I sera were inhibited  by the human blood group 
precursor substance  OG from ovarian cyst fluid  (3,  4)  and two,  Ma and Ort, 
reacted with products of one stage of periodate oxidation and Smith degradation 
(first  104  stage)  of blood group A  and  B  substances.  Quantitative  precipitin 
assays with three anti-I sera, Ma, Ort,  and Step, showed them to be distinctly 
different in specificity as revealed by their reactions with fractions of OG,  1 and 
with  a  human  milk  fraction,  with  cow blood group substances,  and  with  the 
first IO4 stages of A, B, and H  substances. The precipitin reaction between anti- 
I  serum Ma and precursor substance OG was inhibited best by oligosaccharides 
with  terminal  nonreducing/~DGaI(1--+4)/3DGlcNAc(1--+6)-  structure.  This 
structure  was  found  (4)  in  OG substance.  The  determinants  involved in  the 
other I  specificities have not been established. 
Eight other anti-I sera and five anti-i sera have now been studied by quantita- 
tive precipitin assays. They all react strongly with the 20% 2X fraction of OG 
indicating that it contains both I  and i determinants.  Based on their reactions 
with various OG fractions,  the first 104 stages of A, B, and H  substances,  with 
cow substances,  and with  crude hydatid  cyst fluid,  the eleven  anti-I sera can 
be  divided  into  at  least  six groups.  Four  of the five anti-i  sera resembled  one 
* Aided by a grant from the National  Science Foundation  GB-25686 and a  General Re- 
search Support grant from the US Public Health Service to Columbia University. 
:~ Fellow of the Arthritis  Foundation  1969-1972. 
1 Fractions  obtained  after peptic digestion and ethanol precipitation  of cyst fluid, extrac- 
tion  with  90%  phenol,  and  precipitation  by different concentrations  of ethanol  from  the 
phenol (3). 
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another in their strong reaction with OG  20%  2X  while reacting minimally or 
not at all with the other substances,  but  they may  not represent a  single anti- 
body  specificity.  The  fifth differs in that  it  reacts with hydatid  cyst  fluid  and 
with milk. 
Materials and Methods 
The cold agglutinins were typed as anti-I or anti-i (5, 6) on the basis of their relative reac- 
tions with group OI, Oi cord, and Oi adult cells. 
Anti-I sera:  All but one were from patients with the chronic cold agglutinin disease. Case 
Win (7) was a patient with high titer cold agglutinins associated with Mycoplasma pneumonia~ 
infection. The remaining sera have been previously described (1, 2, 8); sera Ma, Oft, and Step 
are included for comparison with the other cold agglutinin sera. 
Anti4 sera:  All five were from patients with chronic cold agglutinin disease. Sera Ho and 
Tho have been previously described (2). Sera Den and McDald were gifts from Mrs.  Marie 
Crookston of the University of Toronto, and case Nic is newly diagnosed. 
Another serum (Ro) with a ~?A cold agglutinin of so-called Prl specificity (9) was provided 
by Dr.  F.  Mullinax of The Medical College of Virginia, Richmond. This cold agglutinin is 
considered to have neither I  nor i  specificity; it  agglutinates all human erythrocytes and 
those of the rat and guinea pig. 
Blood Group and Other Substances.--These have been described earlier (1) and consisted of 
two I  active fractions of human milk (fraction C and 20% 2X) ; human ovarian cyst precursor 
substances OG  (3) and F1  (10); human ovarian cyst A  (MSS)  (11),  B  (Beach)  (12), H  (JS) 
(11), and Le  a  (N-I)  (13)  substances; hog A  +  H  and cow  substances (cf.  reference  1).  In 
addition, the P1  fraction  2 of B  substance  (12,  14)  and the first IO4 stages  (15)  of human 
ovarian cyst A, B, and H  substances and of hog A  +  H  substances were tested (1). A crude 
concentrate of sheep hydatid cyst fluid was also used.  This consisted of pooled lyophilized 
hydatid cyst fluid obtained from sheep livers in New Zealand and was a gift from Dr. J. IV[. 
Stavely, Auckland, New Zealand. The cyst fluid was dissolved in distilled water to achieve a 
tenfold concentration. 
Oligosaccharicles.--3nGal(1  ~  3)DGlcNAc and/~DGal(1 --* 4)DGlcNAc were obtained from 
Dr.  F.  ZilUken  (16),  ~3nGal(1  -~  6)DGNAc and ethyl ~DGIcNAc  from  Dr.  R.  Kuhn  (17). 
A tetrasaccharlde 
~DGlcNAc(1 --~ 6) "~ 
~DGal(1 --~ 4)Dsorbitol  and a pentasaccharlde 
~DGlcNAc(1 --~ 3)  /z 
/~DGIcNAc(1 --~ 6) "-~ 
3DGaI(1  --~ 4)Dsorbitol 
~DGal(1 --* 3)/3DGlcNAc(1  ~  3)/z 
were prepared from human milk by Drs. A.  Kobata and V.  Ginsburg of  the NIH. N-1  RL 
0.41, 0.71b, and 1.1 are oligosaccharides produced  by degradation of  blood group  Le  a  sub- 
stance with NaOD-NaBD4  (13, 2). OG  RL 0.44  and  1.1  are  oligosaccharides produced  by 
degradation of precursor substance OG with NaOD  -- NaBD4  (4, 2). Their structures are as 
follows: 
OG RL 1.1 and N-1 RE 1.1 ~I)Gal(1 --* 4)/39GlcNAc(1 --* 6?)-3-hexenetetrol(s) 
N-1 R L 0.71b/3DGal(1 --~ 4)~l)GlcNAc(1 ~  6)-hexane-l,2,4,5,6-pentol(s) 
OG RL 0.44 and N-1 R L 0.41 
2 The nondialyzable fraction of B substance after heating at 100°C for 2 hr at  pH 1.5-1.8. TEN I~EIZI AND  ELVIN A.  KABAT  1249 
#DGaI(1 ---*  4)/3DGlcNAc 
1 
6 
D-galactitol 
3 
T 
1 
~DGal(1 ~  3)13DGlcNAc 
Quantitative Precipitin and Quantitative Inhibition Assays.--Assays were carried out  at 
0-4°C as previously described (2). 
RESULTS 
Quantitative  Precipitin Studies.--Each serum was tested with five fractions of 
OG and with F1 substance all of which lacked A, B, H, Le  a, and Le  b activities 
and were thus considered as precursors of these blood group substances (3, 10). 
As seen from Figs. 1-3, all anti-I and anti-i sera reacted well with OG 20% 2X. 
Their reactions with the other OG fractions and with F1 were either weaker or 
absent except for anti-I Ma which (cf. reference 2) reacted equally well with all 
of these substances. 
Anti-I sera Ma and Ort had been shown to differ from all other sera tested in 
reacting with milk fraction C, with the first IO4 stages of A  and B  substances 
and with the P1 fraction of human B substance (1, 2). However, each has been 
assigned to a different group (Table I, groups 1 and 2 respectively) since their 
relative reactivities with these substances were different. The remaining anti-I 
sera and all  anti-i sera gave weak or no reactions with these substances,  and 
therefore Ma and Ort were the only specimens in groups 1 and 2, respectively. 
Quantitative precipifin assays with the hydatid cyst fluid and with two cow 
substances 21  and 18, revealed further distinct patterns of reaction among the 
remaining anti-I sera enabling their division into four  additional  groups  (Figs. 
1 and 2 and Table I). Group 3, Step, Sch, Win, and Nay, showed strong reac- 
tions with hydatid cyst fluid and with cow 21. 
Anti-I sera Gre and Da were assigned to groups 4 and 5 respectively, since the 
former reacted well with hydatid cyst fluid and hardly at all with cow 21  and 
the latter reacted well with cow 21 but not at all with hydatid cyst fluid. 
Sera Per, Phi,  and Too constituted group 6 and reacted poorly or not at all 
with cow 21  and with hydatid cyst fluid. 
The anti-i sera, with the exception of McDald,  did not react with the  cow 
substances or with hydatid cyst fluid.  McDald, however,  precipitated moder- 
ately with hydatid cyst fluid and with milk fraction C. 
Two of the anti-I sera in group 3 (Step and Win) reacted moderately with the 
first IO4 stage of human H  substance JS; Step (cf. reference 2), however, reacted 
with hog A +  H  first IO4 stage while Win did not. The other two group 3 sera, 
Sch  and Nay, gave negligible reactions with both  substances suggesting  that Group 1 
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FIG.  1.  Quantitative precipitin  curves for anti-I sera, groups  1,  2,  and  3.* 
* Certain  substances which gave  little  or  no specific precipitation  are not  shown. These 
are: Human A  (MSS), B  (Beach), H  (JS), and hog A  +  H  original substances. In addition, 
cow 18 is not shown with sera Win, Nay, Gre, Per, and Too; Beach P1 is not shown with sera 
Win and Too. Note that the amounts of crude hydatid cyst fluid used as antigen are expressed 
as microliters and not as micrograms, the quantity of active substance being undetermined. 
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this group may eventually be further subdivided. The anti-i sera did not  react 
with the first IO4 stages of J.S. or of hog A +  H. 
Two fractions (phenol insoluble and 10% from 20%) of hmnan Le  a substance 
(N-I) were tested which had earlier been found to cross-react appreciably with 
anti-I Ma and to a lesser extent with Step (2); with the  other  anti-I sera their 
reactions were much weaker or negative. However, when a discernible reaction 
was seen, the 10 % from 20 % fraction reacted more strongly than did the phenol- 
insoluble fraction in agreement with earlier findings. No significant reaction with 
the anti-i sera was found. 
The anti-Prl serum Ro did not precipitate with OG 20 % 2X over a wide range 
of concentrations,  nor did it react with 46  58 ~g of: OG 10% from 20%,  OG 
10% 2N, milk 20% 2N, cow 21, human B (Beach) P1, and the first IO4 stages 
of human A (MSS), B (Beach), H  (JS), and of hog A +  H. 
Relative Proportions  of I  and i Antigenic Determinants on OG 20 % 2X .--From 
Figs. 1-3 it is apparent that the amounts of OG 20 % 2)4 required to precipitate 
a given amount of specific nitrogen vary widely from one anti-I or anti-i serum 
to  another.  This  presumably  reflects differences in  the  numbers  of  I  and  i 
determinants  of  various  specificities  recognized  by  the  sera.  To  make  the 
findings comparable, the data from precipitin curves were adjusted to a uniform 
value of  6 gg of maximum precipitable  antibody  N  and  from  these  curves, 
the quantities  of OG 20%  2)4  required to precipitate 3 pg of N  (50%  of the 
maximum) were read. These data are given in the last column of Table II. It is 
evident that OG 20%  2X  is extremely active in precipitating  anti-I Ma  and 
Ort, only about 3 gg being required for 50 % precipitation, while with all of the 
other groups of anti-I and with all anti-i sera from 4 to 16 times as much OG 
20% 2X was required. Groups 3 and 6 appeared rather uniform while the anti-i 
group  showed considerable  spread  and  might  be considered  to fall into  four 
Symbols: 
OG fractions, 20% 2X  (O) 
10% from 20%  (e) 
10% 2X  (ID) 
20% from 10% ((1) 
Milk fraction C  (Q) 
Milk 20% 2X  (~-) 
~1 (×) 
Cow 21  (&) 
Cow 28 (~X) 
Human A  (MSS)  first IO4 stage (~7) 
Human B  (Beach)  first 104 stage stage (~) 
Beach P1  (~) 
Human Le  a (N-I) phenol insoluble (A) 
X-1 10% of 1st 20%  (m) 
Hydatid cyst fluid (V) 
Hog A -t- H first 104 stage (3) 
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groups.  The  single  examples in the anti-I  groups 4  and  5  differed  from each 
other and from groups 3  and 6. 
i  Quantitative  Inhibition  Assays  with  Oligosaccharides.--Exploratory  assays 
were carried out with anti-I Step and anti-i Tho using OG 20% 2X  as antigen. 
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FIo. 2.  Quantitative  precipitin  curves for anti-I sera,  groups 4,  5, and  6.  For symbols  see 
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There was no significant inhibition of precipitation with any of the oligosac- 
charides at the doses tested (Table III). 
DISCUSSION 
The classification of the  eleven anti-I sera based on their reactivity patterns 
in quantitative precipitin assays with selected blood group substances and with 
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Fro. 3.  Quantitative precipitin curves for anti-i sera. For symbols see Fig. 1. 1254  IMMUNOCHEMICAL  STUDIES  ON  BLOOD  GROUPS.  LIV 
hydatid cyst fluid (Table I)  is consistent with the computation of the relative 
numbers of antigenic determinants on OG 20%  2X  reacting with the various 
antisera  (Table II).  Further subdivisions of group 3  are,  however,  likely since 
they show differences in their reactions with the first IO4 stage of human H  (JS) 
and of hog A  +  H  substances  (Fig.  1 and Table I). The anti-I serum Win ap- 
peared  transiently during convalescence  in  a  patient  with Mycoplasma pneu- 
TABLE I 
Classification  of Anti-I Sera  on the Basis of their Reaction  with OG 20% 2X, 
Cow 21, Milk Fraction  C, Hydatid  Cyst Fluid, and  First 104 Stages 
of A  and B  Substances 
Group  Sera  OG 20%  Cow 21  Hydatid  Milk  A and B  2 X  cyst fluid  fraction  C  first IO4  Comments 
stages 
1  Ma  Strong  Strong  \:ery weak  Strong  Strong  All  OG  fractions  reacted 
strongly as did F1  (1, 2) 
2  Ort  Strong  Strong  n.d.*  Mod.  Mod.  Reaction  with  milk  and 
with the first 104 stages of 
A  and  B  substances  was 
half as strong as with OG 
20%  2X.  Other  OG  frac- 
tions  and  FI  reacted  in 
an  intermediate  manner 
(1, 2) 
3  Step,  Sch,  Strong  Strong  Strong  Neg. or  Neg. or 
Win, Nay  weak  weak 
Variations  within  group  in 
relative  reactions  with 
OG fractions and Mth the 
first  IO4 stages of human 
It  and  hog  A  +  H  sub- 
stances 
4  Gre  Stlong  Very weak  Strong  Neg.  Neg.  Other  OG  fractions  very 
weak or negative 
5  Da  Strcng  Strong  Neg.  Very weak  Neg.  Other  OG  fractions  very 
weak:  or negative 
6  Per,  Phi,  Strong  Neg. or  Neg. or  Neg. or  Neg.  Other  OG  fractions  ,nod- 
Too  weak  weak  weak  erate or weak 
*Not  tested. 
moniae infection. It fell into group 3 together with three anti-I sera from patients 
with chronic cold agglutinin  disease. These latter  antibodies  are Waldenstr6m 
macroglobulins.  Anti-I  Win  resembled  the  Waldenstr6m  macroglobulins  in 
having only kappa chains of restricted mobility in acid urea starch gel electro- 
phoresis (7). The computations in Table II for anti-i sera suggest that there are 
at least four kinds of anti-i specificities. 
The negative reaction of the anti-Prl serum Ro with OG 20% 2X  indicates 
that this glycoprotein though  complex contains only a limited  number  of de- 
terminants. TEN  FEIZI AND  ELVIN A.  KABAT  1255 
The differences in the reactions of the various blood group glycoproteins with 
the  anti-I and anti-i sera  are  now clearly attributable to  differences in their 
relative proportions of minor populations of incomplete chains with various I 
and i  specificities as has been emphasized previously (2). Thus while the first 
IO4 stages of A and B substances create I  determinants from complete A and B 
determinants by exposing receptors reacting with anti-I Ma and Ort, they may 
TABLE  II 
Estimate of Reh tire Numbers  of Antigenic  Deierminants  on OG 20~o 2~( Reacting with Various 
Anti-I and Anti-i Sera 
Maximum  Amount  OG 20% 2X needed to  Amount  OG 20% 2X needed to 
Group  Antibody  antibody  N  precipitate  50% of the  precipitate  3 #g N, when total 
precipitated  antibody  antibody  is converted  to 6  #g N 
Anti-I  tzg  Ng  izg 
Ma  6  3  3 
Ort  7  3  2.6 
Step  19  52  16 
Win  6  20  20 
Sch  8  24  18 
Nay  20  76  23 
Gre  10  58  35 
Da  8  57  43 
Per  7.5  26  21 
Too  15  63  25 
Phi  6  18  18 
Anti-i 
McDald  20  40  12 
Tho  48  115  14 
Den  5.5  20  22 
Ho  19  90  28 
Nic  8.8  73  50 
also uncover or destroy receptors reacting with the other anti-I or anti-i sera 
depending on  the  heterogeneity with respect  to  incomplete A  and B  deter- 
minants of the original A  and B  substances. 
The differences in Table II in the amounts of OG 20% 2X  required to pre- 
cipitate 50 %  of the antibody from the various anti-I and anti-i sera indicate 
that it contains the different I  and i determinants in appreciable propomons. 
This might be  due to  incomplete biosynthesis or might also be the  result of 
degradation in the cyst cavity. It becomes of importance to establish whether 
similar variations in the numbers of receptors with these distinct specificities 1256  IMMUNOCttEMICAL  STUDIES  ON  BLOOD  GROUPS.  LIV 
can  be found  on  erythrocytes or on freshly secreted soluble blood group  sub- 
stances. 
Inhibition assays with the available oligosaccharides (Table III) were entirely 
negative. Thus information on the structures of the determinants reacting with 
the  anti-I  and  anti-i  other  than  anti-I Ma  (2)  are  completely lacking.  The 
limited amounts  of oligosaccharides from N-1  and OG cysts precluded assays 
TABLE III 
Maximum  Amounts  of Oligosaccharides  Used in  Quantitative Inhibition  Assays  with Anti-I 
Serum Step and Anti4 Serum Tho* 
Oligosaccharide 
Maximum amount 
Serum Step  Serum Tho 
Izmoles 
Ethyl-~-GlcNAc  19.3  5.9 
,SDGal(1 --* 3)DGlcNAc  5.0  5.1 
BDGal(1 --* 4)9GlcNAc  5.2  5.0 
~DGal(1 ~  6)DGlcNAc  3.7  5.3 
N-1 Re 1.1  0.9  n.d. 
OG RL 1,1  n.d.:~  0.94 
N-1 RL 0.71b  0.3  0.3 
N-1 RL 0.41  0.6  n.d. 
OG RL 0.44  n.d.  0.4 
BoGlcNAc(1 --~ 6) 
¢~DGal  (1 --* 4)DSorbitol  0.9  n.d. 
7 
~DGal(1 --* 3)BDGIcNAc(1 --* 3) 
flDGlcNAc(1 --~ 6) 
¢~DGal(1 --* 4)DSorbitol  0.9  n.d. 
7 
/~DGlcNAc(1 --~ 3) 
* None  of these  oligosaccharides  inhibited the  precipitation of  the  two  antisera with 
OG 20% 2X. 
~; Not tested. 
at  higher  concentrations  of  inhibitor.  Thus  one  cannot  be  sure  whether  the 
other anti-I and anti-i sera have specificity involving different determinants or 
whether  the  specificity  is  directed  toward  determinants  of  larger  size  (cf. 
reference 18), and the smaller oligosaccharides tested were not used in sufficient 
concentration to inhibit. 
SUMMARY 
Quantitative  precipitin assays were  carried out  with  eleven anti-I and five 
anti-i cold agglutinin sera.  Their  reaction patterns  with  precursor substances 
and with certain antigens related to the A, B, H, Le%  and Le  b substances re- TEN  FEIZI  AND  ELVIN  A.  KABAT  1257 
vealed at least six types of I  and four types of i  specificity. All of the I  and i 
determinants appear to be represented in varying amounts on that fraction of 
the  ovarian  cyst  precursor  substance  OG  which  was  precipitated  by  20% 
ethanol (OG 20% 2X). Only some of these determinants can be detected in the 
first periodate oxidation stages of A, B,  and H  substances,  in cow substances, 
and in hydatid cyst fluid. 
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